2019
DOI: 10.1074/jbc.ra119.009791
|View full text |Cite
|
Sign up to set email alerts
|

The yeast pantothenate kinase Cab1 is a master regulator of sterol metabolism and of susceptibility to ergosterol biosynthesis inhibitors

Abstract: are listed on a patent application for targeting pantothenate kinase (PanK) activity for development of antifungal drugs. Choukri Ben Mamoun is the founder of a company that aims to develop such drugs. This article contains Figs. S1 and S2.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 23 publications
0
20
0
Order By: Relevance
“…As recently demonstrated, the deficit in PANK in yeast leads to different levels of sterol intermediates [ 42 ] and in a yeast model of CoPAN showing a 40% reduction of coenzyme A, the content of intracellular lipid droplets is reduced [ 33 ]. We then evaluated the content of intracellular lipid droplets in the PKAN yeast model.…”
Section: Resultsmentioning
confidence: 99%
“…As recently demonstrated, the deficit in PANK in yeast leads to different levels of sterol intermediates [ 42 ] and in a yeast model of CoPAN showing a 40% reduction of coenzyme A, the content of intracellular lipid droplets is reduced [ 33 ]. We then evaluated the content of intracellular lipid droplets in the PKAN yeast model.…”
Section: Resultsmentioning
confidence: 99%
“…either maintain or only partially reduce enzyme activity. Unlike higher eukaryotes, which express more than one PANK enzyme, fungi encode a single PANK ortholog (22). The S. cerevisiae Pank ortholog, Cab1, is particularly interesting due to its J o u r n a l P r e -p r o o f essential role in cell viability as well as for the presence of mutants that display cell biological defects similar to those seen in PKAN cells.…”
Section: Mitigation Of Negative Regulation May Partially Explain Why ...mentioning
confidence: 99%
“…In recent years, several animal models of PKAN have been developed, but translation of this knowledge to humans is hampered by physiological and metabolic differences between model organisms and humans ( 11 , 13 , 14 , 15 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ). One key difference is that while all the species used share a homologous pantothenate kinase gene, the number of different orthologs and subcellular localization of the encoded proteins often vary.…”
Section: Models Of Pkanmentioning
confidence: 99%
See 1 more Smart Citation
“…The first step is likely catalyzed by glutamate-cysteine ligase (Gcs1), which catalyzes the condensation of Cys and glutamate to form γ-glutamylcysteine, which is then converted to GSH by the addition of Gly to the C-terminal of γ-glutamylcysteine by glutathione synthase (Gsh2) (Chen et al, 2009). Moreover, both Cys and pantothenic acid are key precursors of the thiol-containing Coenzyme A in yeast, and in other fungi (Chiu et al, 2019). CoA is not only an important co-factor for enzyme-catalyzed reactions, but is the source of 4 -phosphopantetheine for essential post-translational activation of non-ribosomal peptide synthetases and polyketide synthases in fungi (Stack et al, 2009;Sheridan et al, 2015).…”
Section: Biosynthesis Of Sulfur-containing Amino Acids and Metabolitesmentioning
confidence: 99%